2024
Managing menopause after cancer
Hickey M, Basu P, Sassarini J, Stegmann M, Weiderpass E, Nakawala Chilowa K, Yip C, Partridge A, Brennan D. Managing menopause after cancer. The Lancet 2024, 403: 984-996. PMID: 38458217, DOI: 10.1016/s0140-6736(23)02802-7.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsFemaleHormone Replacement TherapyHot FlashesHumansMenopauseQuality of LifeConceptsPremature ovarian insufficiencyMenopausal symptomsRisk of chronic conditionsLong-term effects of cancer treatmentHormone therapyOvarian insufficiencyPatient-focused modelModels of careVasomotor symptomsBreast cancerEffects of cancer treatmentCancer treatmentSexual dysfunctionHigh-income countriesMenopausal hormone therapyQuality of lifeTreatment-induced symptomsLow-income countriesNon-hormonal treatmentsNon-hormonal optionsChronic conditionsManaging menopausal symptomsManaging menopauseDiagnose menopauseVaginal estrogenBMI and breast cancer risk around age at menopause
Von Holle A, Adami H, Baglietto L, Berrington de Gonzalez A, Bertrand K, Blot W, Chen Y, DeHart J, Dossus L, Eliassen A, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson S, Heath A, Jones M, Joshu C, Kaaks R, Kirsh V, Kitahara C, Koh W, Linet M, Park H, Masala G, Mellemkjaer L, Milne R, O'Brien K, Palmer J, Riboli E, Rohan T, Shrubsole M, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen R, Weiderpass E, Willett W, Yuan J, Zeleniuch-Jacquotte A, Nichols H, Sandler D, Swerdlow A, Schoemaker M, Weinberg C. BMI and breast cancer risk around age at menopause. Cancer Epidemiology 2024, 89: 102545. PMID: 38377945, PMCID: PMC10942753, DOI: 10.1016/j.canep.2024.102545.Peer-Reviewed Original ResearchMeSH KeywordsAdultBody Mass IndexBreast NeoplasmsFemaleHumansMenopauseMiddle AgedPremenopauseProspective StudiesRisk FactorsYoung AdultConceptsBreast cancer riskCancer riskHazard ratioBreast cancer hazard ratioCancer hazard ratioFive-unit incrementNatural menopauseBreast cancer etiologyHigher body mass indexLoss to follow-upAssociated with decreased riskBreast cancer diagnosisMenopausal status groupsBody mass indexYears age rangeMenopausal hormone therapyPrimary time scalePerson-timeCancer etiologyLoss of ovarian functionCancer diagnosisMass indexBMIPositive associationStatus groups
2023
Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study
Hughes D, Schomburg L, Jenab M, Biessy C, Méplan C, Moskal A, Sun Q, Demircan K, Fedirko V, Weiderpass E, Mukhtar M, Olsen A, Tjønneland A, Overvad K, Schulze M, Nøst T, Skeie G, Olsen K, Ricceri F, Grioni S, Palli D, Masala G, Tumino R, Pasanisi F, Amiano P, Colorado Yohar S, Agudo A, Sánchez M, Ardanaz E, Sund M, Andersson A, Perez-Cornago A, Travis R, Heath A, Dossus L. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study. Free Radical Biology And Medicine 2023, 209: 381-393. PMID: 37923090, DOI: 10.1016/j.freeradbiomed.2023.10.401.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsCohort StudiesFemaleHumansProspective StudiesSeleniumSelenoprotein PSelenoproteinsConceptsAssociated with BC riskBC riskCase-control pairsOdds ratioMultivariable-adjusted logistic regression modelsBreast cancer riskInfluence BC riskCancer and NutritionConfidence intervalsEuropean Prospective InvestigationHigher risk of BCPremenopausal BC riskRisk of BCPrevent breast cancerAssociated with lower riskEuropean cohort studiesBreast cancerGenetic variant associationsLogistic regression modelsGlutathione peroxidase 3Multiple testing correctionStatistically significant associationPremenopausal BCCancer riskVariant associations